Evidence-based medicine: Context and relevance;Evidence-based medicine: Kontext und relevanz 'evidenzgestutzter medizin'

Zeitschrift fur Gastroenterologie

Volumn 37, Issue 6, 1999, Pages 525-533

  Raspe, H ^b   Stange, E F ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b NONE

Author keywords

Evidence based medicine

Indexed keywords

CLINICAL MEDICINE; EMPIRICISM; EVIDENCE BASED MEDICINE; HEALTH CARE; MEDICAL ASSESSMENT; MEDICAL LITERATURE; REVIEW;

EVALUATION STUDIES; EVIDENCE-BASED MEDICINE; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY;

EID: 0032843748     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Naunyn B. Aerzte und Laien. Deutsche Revue 1905; 30. Jg.: 343-55
2. Hiatt H, Goldmann L. Making medicine more scientific. Nature 1994; 371: 100
3. Smith R. The scientific basis of health services. BMJ 1995; 311: 961-2
4. Nieschlag E. Aufgaben und Ziele der Andrologie. In: Nieschlag E, Behre HM (Hrsg.). Andrologie. Berlin, Springer, 1996, 1-9
5. Feinstein AR. Clinimetrics. New Haven, Yale University Press, 1987
6. Last J (Hrsg.). A dictionary of epidemiology. New York, Oxford, Toronto, Oxford University Press, 1995, 3rd ed., 47
7. Sackett DL, Rosenberg WMC, Muir Gray JA et al. Evidence-based medicine: What it is and what it isn't. BMJ 1996; 312: 71-2
8. Relman AS. Assessment and accountability. The third revolution in medical care. N Engl J Med 1988; 319: 1220-2
9. Epstein AM. The outcomes movement - will it get us where we want to go? N Engl J Med 1990; 232: 266-70
10. Tröhler U. To improve the evidence of medicine: Arithmetic observation in clinical medicine in the eighteenth and early nineteenth centuries. Hist Phil Life Sci 1988; 10 (suppl.): 31-40
11. Lind J. The most promising treatments for scurvy. In: Pocock SJ: Clinical trials. Chichester, New York, Wiley & Sons, 1983, 14
12. Winau R. Vom kasuistischen Behandlungsversuch zum kontrollierten klinischen Versuch. In: Helchen H. Winau R (Hrsg.). Versuche mit Menschen in Medizin, Humanwissenschaft und Politik. Berlin, de Gruyter, 1986
13. Vandenbrouke JP. A short note on the history of the randomized controlled trial. J Chron Dis 1987; 40: 985-7
14. Evans JG. Evidence-based and evidence-biased medicine. Age Ageing 1995; 24: 461-3
15. Sackett D. Clinical epidemiology. Am J Epidemiol 1969; 89: 125-8
16. Feinstein AR. Clinical epidemiology: The architecture of clinical research. Philadelphia, Saunders, 1985
17. Spitzer WO. Clinical epidemiology. J Chron Dis 1986; 39: 411-5
18. Holle R. Klinische Epidemiologie - Versuch einer Standortbestimmung aus der Sicht der Medizinischen Biometrie. In: Kunath H, Lochmann U, Straube R et al. (Hrsg.). Medizin und Informatik. 39. Jahrestagung der GMDS und DAE in Dresden 1994. München, MMV Medizin Verlag, 1994
19. Martini P. Methodenlehre der therapeutisch-klinischen Forschung. Berlin, Springer, 1932
20. Todd JW. The errors of medicine. Lancet, March 1970, 665-70
21. Shepherd J, Cobbe SM, Ford I et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-7
22. Chalmers I. What do I want from health research and researchers when I am a patient? BMJ 1995; 310: 1315-8
23. Antmann EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. JAMA 1992; 268: 240-8
24. Davidoff F, Haynes B, Sackett D, Smith R. Evidence-based medicine: A new journal to help doctors identify the information they need. BMJ 1995; 310: 1085-6
25. Stelfox HT, Chua G, O'Rourke K, Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med 1998; 338: 101-6
26. Davis DA, Thompsen MA, Oxmann AD, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 1994; 274: 700-5
27. Guyat GH, Sackett DL, Cook DJ for the Evidence-Based Medicine Working Group. Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? JAMA 1993; 270: 2598-601
28. Egger M, Zellweger T, Antes G. Randomised trials in German-language journals (letter). Lancet 1990; 347: 1047-8
29. Begg C, Cho M, Eastwood S et al. Improving the quality of reporting of randomized controlled trials. JAMA 1996; 270: 637-9
30. Camma C, Giunta M, Rosselli M, Cottone M. Mesalamine in the maintenance treatment of Crohn's disease: A meta-analysis adjusted for confounding variables. Gastroenterology 1997; 113: 1465-73
31. Naylor CD. Crey zones of clinical practice: Some limits to evidence-based medicine. Lancet 1995; 345: 840-2
32. Jadad AR, Cook DJ, Browman GP. A guide to interpreting discordant systematic reviews. CMJA 1997; 156: 1411-6
33. Raspe HH. Evidence-based medicine: Modischer Unsinn, alter Wein in neuen Schläuchen oder aktuelle Notwendigkeit? Z Arztl Fortbild Qualitätssich 1996; 90: 553-62
34. Raspe H. Evicence-based medicine: Anlässe, Methoden, Probleme, Geburtsh Frauenheilk 1998; 58: M21-M25
35. LeLorier J, Grégoire G, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997; 337: 536-42
36. Stange EF, Schreiber S, Raedler A et al. Therapie des Morbus Crohn - Ergebnisse einer Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs-und Stoffwechselkrankheiten. Z Gastroenterol 1997; 35: 541-4